Sickle Cell Disease

Lobe Sciences announced the validation of its European Unitary Patent EP4117446 across 17 EU member states, covering its proprietary DHA-based composition for Sickle Cell Disease (SCD). This patent protects Altemia®, an innovative medical food designed to improve red blood cell integrity and address fatty acid deficiencies in SCD patients. The validation significantly strengthens Lobe’s intellectual property in crucial European territories, advancing its commercialization roadmap for Altemia®.